[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ligand Pharm (LGND)

Ligand Pharm (LGND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,293,676
  • Shares Outstanding, K 20,041
  • Annual Sales, $ 268,090 K
  • Annual Income, $ 124,450 K
  • EBIT $ 127 M
  • EBITDA $ 157 M
  • 60-Month Beta 1.17
  • Price/Sales 22.70
  • Price/Cash Flow 38.66
  • Price/Book 6.10

Options Overview Details

View History
  • Implied Volatility 44.07% (-0.85%)
  • Historical Volatility 34.84%
  • IV Percentile 75%
  • IV Rank 34.16%
  • IV High 73.14% on 04/13/26
  • IV Low 28.98% on 08/08/25
  • Expected Move (DTE 16) 24.96 (7.90%)
  • Put/Call Vol Ratio 0.64
  • Today's Volume 46
  • Volume Avg (30-Day) 60
  • Put/Call OI Ratio 0.69
  • Today's Open Interest 1,149
  • Open Int (30-Day) 968
  • Expected Range 291.13 to 341.05

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.26
  • Number of Estimates 3
  • High Estimate $1.63
  • Low Estimate $1.06
  • Prior Year $0.24
  • Growth Rate Est. (year over year) +425.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
222.76 +41.90%
on 06/01/26
320.99 -1.53%
on 06/30/26
+84.13 (+36.27%)
since 05/29/26
3-Month
192.96 +63.81%
on 03/31/26
320.99 -1.53%
on 06/30/26
+123.45 (+64.08%)
since 03/30/26
52-Week
111.71 +182.94%
on 07/02/25
320.99 -1.53%
on 06/30/26
+202.41 (+178.05%)
since 06/30/25

Most Recent Stories

More News
Ligand Announces Closing of Convertible Senior Notes Offering

Opportunistic capital raise with proceeds used to enhance financial flexibility A portion of the proceeds to be used to purchase call spreads and to fund concurrent share repurchase intended to offset...

LGND : 316.09 (+0.65%)
Ligand Announces Pricing of Upsized $625 Million Convertible Senior Notes Offering

Opportunistic capital raise with proceeds used to enhance financial flexibility A portion of the proceeds to be used to purchase call spreads and to fund concurrent share repurchase intended to offset...

LGND : 316.09 (+0.65%)
Stocks Mostly Lower on Weakness in Megacap Tech and Software Stocks

The S&P 500 Index ($SPX ) (SPY ) on Monday closed down -0.37%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.19%. September...

GOOGL : 357.37 (+1.05%)
AAPL : 289.36 (+2.70%)
SNDK : 2,273.73 (+10.89%)
ADI : 397.17 (+1.38%)
TSLA : 420.60 (+2.13%)
STX : 965.00 (-0.36%)
AMD : 580.91 (+7.68%)
DFTX : 47.04 (+1.05%)
SPY : 746.77 (+0.78%)
META : 563.29 (+0.12%)
NOC : 509.31 (+2.68%)
FRVO : 29.23 (-7.99%)
Stocks Erase Early Gains as Alphabet and Software Companies Fall

The S&P 500 Index ($SPX ) (SPY ) today is down -0.40%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.27%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.30%. September E-mini S&P futures...

MSTR : 86.93 (-6.20%)
GOOGL : 357.37 (+1.05%)
SNDK : 2,273.73 (+10.89%)
COIN : 146.19 (-3.60%)
STX : 965.00 (-0.36%)
AMD : 580.91 (+7.68%)
DFTX : 47.04 (+1.05%)
^BTCUSD : 58,791.60 (+0.28%)
SPY : 746.77 (+0.78%)
NOC : 509.31 (+2.68%)
FRVO : 29.23 (-7.99%)
ADSK : 194.42 (-0.42%)
Stocks Supported by Strength in Chipmakers and AI-Infrastructure Stocks

The S&P 500 Index ($SPX ) (SPY ) today is up +0.21%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.54%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.50%. September E-mini S&P futures...

MSTR : 86.93 (-6.20%)
AMAT : 723.00 (+4.08%)
GOOGL : 357.37 (+1.05%)
SNDK : 2,273.73 (+10.89%)
GLXY : 27.34 (-4.17%)
$IUXX : 30,276.35 (+1.68%)
COIN : 146.19 (-3.60%)
ZNU26 : 109-195 (-0.26%)
LGND : 316.09 (+0.65%)
APGE : 132.73 (+0.09%)
ESU26 : 7,531.00 (-0.23%)
STX : 965.00 (-0.36%)
Ligand Announces Proposed Offering of $550 Million of Convertible Senior Notes Due 2031

Opportunistic capital raise with proceeds used to enhance financial flexibility  A portion of the proceeds to be used to purchase call spreads and to fund concurrent share repurchase intended to...

LGND : 316.09 (+0.65%)
Ligand Announces 2026 Investor Day in New York City

JUPITER, Fla., June 10, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will host an Investor Day in New York City on Tuesday, December 8, 2026 at...

LGND : 316.09 (+0.65%)
Ligand to Participate in June Investor Conferences

JUPITER, Fla., May 27, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its senior management team will participate in the following upcoming investor...

LGND : 316.09 (+0.65%)
Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates

Orchestra BioMed targeting enrollment completion of BACKBEAT Global Pivotal Trial (“BACKBEAT Trial”) by the end of Q3 2026 Medtronic (NYSE: MDT) and Orchestra BioMed intend to pursue late-breaking...

LGND : 316.09 (+0.65%)
MDT : 78.23 (-3.34%)
OBIO : 4.32 (-9.16%)
Ligand Pharmaceuticals Q1 Earnings Call Highlights

Ligand Pharmaceuticals (NASDAQ:LGND) reported first-quarter 2026 results that management said reflect the operating leverage of its royalty aggregation strategy, highlighted by growing royalties from key...

LGND : 316.09 (+0.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 80%. The market is in extreme overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Ligand, being a biotechnology company, focuses on developing/acquiring royalty revenue generating assets and coupling them with a lean corporate cost structure. Ligand's Captisol formulation technology has allowed it to enter into several licensing deals and generate royalties. Captisol is a well validated...

See More

Key Turning Points

3rd Resistance Point 329.79
2nd Resistance Point 325.39
1st Resistance Point 320.74
Last Price 316.09
1st Support Level 311.69
2nd Support Level 307.29
3rd Support Level 302.64

See More

52-Week High 320.99
Last Price 316.09
Fibonacci 61.8% 241.05
Fibonacci 50% 216.35
Fibonacci 38.2% 191.66
52-Week Low 111.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.